Immediate Impact
51 standout
Citing Papers
Pancreatic cancer
2025 Standout
In Situ Rapid‐Formation Sprayable Hydrogels for Challenging Tissue Injury Management
2024 Standout
Works of E. Dapretto being referenced
Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E. Dapretto | 132 | 386 | 101 | 135 | 6 | 463 | |
| Karin Rita Tamas | 158 | 482 | 159 | 206 | 5 | 542 | |
| Eva–Maria Duerr | 66 | 209 | 56 | 186 | 8 | 551 | |
| Ren-bao Yang | 102 | 283 | 66 | 122 | 9 | 443 | |
| Yongshuai Jiang | 75 | 282 | 34 | 53 | 6 | 495 | |
| Takashi Shinya | 70 | 170 | 36 | 288 | 8 | 520 | |
| He-Li Gao | 95 | 305 | 47 | 166 | 10 | 513 | |
| Linda Henry | 38 | 205 | 89 | 107 | 11 | 446 | |
| Mauro Iannopollo | 81 | 305 | 64 | 110 | 10 | 449 | |
| Zi-Hao Qi | 78 | 264 | 47 | 164 | 9 | 512 | |
| James E. Krook | 134 | 294 | 90 | 109 | 9 | 421 |
All Works
Loading papers...